Piramal Enterprises approves share buyback worth ₹1,750 cr
Buyback represents 5.87% of total paid-up equity share capital at ₹1,250 apiece, a 16.51% premium over Friday's closing price
Buyback represents 5.87% of total paid-up equity share capital at ₹1,250 apiece, a 16.51% premium over Friday's closing price
Lists Piramal Pharma Ltd (PPL) on stock exchanges, with 35% stake with Piramal family and 20% with Carlyle Group.
Restructuring to simplify corporate structure, create two separate listed entities.
The acquisition—which entails PCHFL’s merger with DHFL—will create one of the largest affordable housing finance companies in India.
Billionaire industrialist Ajay Piramal is in makeover mode. He wants to remould his conglomerate into a well-diversified NBFC and a pharma firm, which would both be giants in their respective spaces.
Lenders decide to pay FD depositors holding up to ₹2 lakh the full amount while other depositors will face the distribution mechanism.
The tycoon has finally won DHFL in a bruising bidding war. Here's Fortune India's earlier story explaining why the ailing home finance company is critical to his plans.
Nita Ambani is putting in place entrepreneurial and philanthropic projects of global scale. That makes her an inspiration for millions of Indians.
The deal with the U.S.-based Clarivate will give Piramal Enterprises much needed liquidity to invest in its NBFC business.
Are conglomerates making a comeback or have they completely lost all relevance?They’ve never really gone away, at least in India. Here’s why they are unlikely to vanish in the future either.